Literature DB >> 14566315

Validity of the Titmus and Randot circles tasks in children with known binocular vision disorders.

Sherry L Fawcett1, Eileen E Birch.   

Abstract

PURPOSE: The Titmus and Randot (version 2) circles tests contain monocular form cues that may enable patients with binocular vision disorders to pass without any measurable stereopsis. The purpose of this study was to evaluate the validity of the Randot and Titmus circles tests for quantifying stereoacuity in children with known binocular vision disorders.
METHODS: Participants included 170 consecutive children with diverse binocular sensory function ranging from fine to no measurable stereopsis. Stereoacuity was measured using the Randot circles, the Titmus circles, and the Randot Preschool Stereoacuity tests.
RESULTS: Discrepancies between stereoacuity scores derived using either the Titmus or Randot circles tests and the Randot Preschool Stereoacuity test increased as a function of random-dot stereoacuity. Stereoacuity scores derived using the circles tests showed good agreement with random-dot stereoacuity when stereoacuity was 2.2 log seconds of arc (160 seconds of arc) or better, but they progressively overestimated stereoacuity for poorer random-dot stereoacuity scores.
CONCLUSION: When measuring stereoacuity using either the Titmus or Randot circles tests in patients with known binocular vision disorders, stereoacuity scores > 2.2 log seconds of arc should be interpreted with caution because it is above this level of stereoacuity that the monocular form cues of each of the tests may invalidate the results.

Entities:  

Mesh:

Year:  2003        PMID: 14566315     DOI: 10.1016/s1091-8531(03)00170-8

Source DB:  PubMed          Journal:  J AAPOS        ISSN: 1091-8531            Impact factor:   1.220


  21 in total

1.  Depth perception in patients with congenital color vision deficiency.

Authors:  Serdar Ozates; Mehmet Ali Sekeroglu; Cagri Ilhan; Sibel Doguizi; Pelin Yilmazbas
Journal:  Eye (Lond)       Date:  2018-12-05       Impact factor: 3.775

2.  Effect of age on adult stereoacuity as measured by different types of stereotest.

Authors:  L Garnham; J J Sloper
Journal:  Br J Ophthalmol       Date:  2006-01       Impact factor: 4.638

3.  The influence of refractive error management on the natural history and treatment outcome of accommodative esotropia (an American Ophthalmological Society thesis).

Authors:  Bradley Charles Black
Journal:  Trans Am Ophthalmol Soc       Date:  2006

4.  Intraexaminer repeatability and agreement in stereoacuity measurements made in young adults.

Authors:  Beatriz Antona; Ana Barrio; Isabel Sanchez; Enrique Gonzalez; Guadalupe Gonzalez
Journal:  Int J Ophthalmol       Date:  2015-04-18       Impact factor: 1.779

5.  A binocular iPad treatment for amblyopic children.

Authors:  S L Li; R M Jost; S E Morale; D R Stager; L Dao; D Stager; E E Birch
Journal:  Eye (Lond)       Date:  2014-07-25       Impact factor: 3.775

Review 6.  Stereo vision and strabismus.

Authors:  J C A Read
Journal:  Eye (Lond)       Date:  2014-12-05       Impact factor: 3.775

Review 7.  Stereopsis and amblyopia: A mini-review.

Authors:  Dennis M Levi; David C Knill; Daphne Bavelier
Journal:  Vision Res       Date:  2015-01-29       Impact factor: 1.886

8.  Dichoptic movie viewing treats childhood amblyopia.

Authors:  Simone L Li; Alexandre Reynaud; Robert F Hess; Yi-Zhong Wang; Reed M Jost; Sarah E Morale; Angie De La Cruz; Lori Dao; David Stager; Eileen E Birch
Journal:  J AAPOS       Date:  2015-10       Impact factor: 1.220

9.  Validation of dynamic random dot stereotests in pediatric vision screening.

Authors:  Anna Budai; András Czigler; Eszter Mikó-Baráth; Vanda A Nemes; Gábor Horváth; Ágota Pusztai; David P Piñero; Gábor Jandó
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-10-03       Impact factor: 3.117

10.  Horizontal Lang two-pencil test as a screening test for stereopsis and binocularity.

Authors:  Monisha E Nongpiur; Pradeep Sharma
Journal:  Indian J Ophthalmol       Date:  2010 Jul-Aug       Impact factor: 1.848

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.